Abstract
Viral infection in animals and plants is a serious problem worldwide. It causes dramatic losses in health and economy. Many approaches to combat with viral infectious diseases have been intensively investigated. Measures taken against viral infections can either aim for protecting from viral infection or eliminating the viruses after infection. RNA dependent RNA polymerase (RdRp) is a key enzyme for viral replication and found in all positive strand RNA viruses. Disturbing the RdRp activity therefore results in reducing or inhibiting the virus infection. In this review we focus on reviewing different strategies and agents to inhibit the RdRps of different mammalian and plant positive-sense (ss) RNA viruses. The strategies described in this review are mainly focusing on interference of the nucleotides which are the substrates need for RdRp and blocking the RdRp itself by using chemical agents or antibodies specifically binding to the different domains of the RdRps. Moreover using small interfering (si) RNA technology platform to inhibit the RdRp activity is also discussed.
Current Enzyme Inhibition
Title: Inhibitions of Positive-Sense (ss) RNA Viruses RNA-Dependent RNA Polymerases
Volume: 5 Issue: 4
Author(s): Kajohn Boonrod and Gabriele Krczal
Affiliation:
Abstract: Viral infection in animals and plants is a serious problem worldwide. It causes dramatic losses in health and economy. Many approaches to combat with viral infectious diseases have been intensively investigated. Measures taken against viral infections can either aim for protecting from viral infection or eliminating the viruses after infection. RNA dependent RNA polymerase (RdRp) is a key enzyme for viral replication and found in all positive strand RNA viruses. Disturbing the RdRp activity therefore results in reducing or inhibiting the virus infection. In this review we focus on reviewing different strategies and agents to inhibit the RdRps of different mammalian and plant positive-sense (ss) RNA viruses. The strategies described in this review are mainly focusing on interference of the nucleotides which are the substrates need for RdRp and blocking the RdRp itself by using chemical agents or antibodies specifically binding to the different domains of the RdRps. Moreover using small interfering (si) RNA technology platform to inhibit the RdRp activity is also discussed.
Export Options
About this article
Cite this article as:
Boonrod Kajohn and Krczal Gabriele, Inhibitions of Positive-Sense (ss) RNA Viruses RNA-Dependent RNA Polymerases, Current Enzyme Inhibition 2009; 5 (4) . https://dx.doi.org/10.2174/157340809789630262
DOI https://dx.doi.org/10.2174/157340809789630262 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Forkhead Transcription Factor FOXO3a Controls Microglial Inflammatory Activation and Eventual Apoptotic Injury through Caspase 3
Current Neurovascular Research Structure Function Analysis of West Nile Virus RNA Dependent RNA Polymerase: Molecular Model and Implications for Drug Design
Medicinal Chemistry Dengue: Recent Advances in Biology and Current Status of Translational Research
Current Molecular Medicine Combinatorial Approaches to Iminosugars as Glycosidase and Glycosyltransferase Inhibitors
Combinatorial Chemistry & High Throughput Screening Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy
Current HIV Research Acanthamoeba-Bacteria: A Model to Study Host Interaction with Human Pathogens
Current Drug Targets TRIM65 in White Matter Lesions, Innate Immunity, and Tumor
Current Molecular Pharmacology The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design Recent Developments in Delivery of Nucleic Acid-Based Antiviral Agents
Current Pharmaceutical Design Editorial: Overview on microRNAs in Cancer Development and Virus Infection
MicroRNA Update On Emerging Antivirals For The Management Of Herpes Simplex Virus Infections: A Patenting Perspective
Recent Patents on Anti-Infective Drug Discovery Jembrana Disease Virus: Host Responses, Viral Dynamics and Disease Control
Current HIV Research Macrophage Derived Cystatin B/Cathepsin B in HIV Replication and Neuropathogenesis
Current HIV Research A Feature-Free 30-Disease Pathological Brain Detection System by Linear Regression Classifier
CNS & Neurological Disorders - Drug Targets Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Immunoinformatic Approach for the Identification of Potential Epitopes Against <i>Stenotrophomonas maltophilia</i>: A Global Opportunistic Pathogen
Letters in Drug Design & Discovery CC Chemokine Receptor Small Molecule Antagonists in the Treatment of Rheumatoid Arthritis and Other Diseases: A Current View
Current Topics in Medicinal Chemistry Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia
Current HIV Research Brucella Pneumonia with Systemic Complications and Pancytopenia: A Case Report
Infectious Disorders - Drug Targets The Potential for Genetically Altered Microglia to Influence Glioma Treatment
CNS & Neurological Disorders - Drug Targets